Active hexose correlated compound (AHCC) is a natural compound extracted from shiitake mushrooms. It was developed in Japan in 1989, and has since been used to improve the immunity of over 100,000 patients, and has been studied in over 50 human clinical trials. AHCC has the unique ability to stimulate the immune system, which is important in controlling inflammation and infection and regulating healthy cell growth.
AHCC is used alongside chemotherapy treatments in many Japanese hospitals for its immune supportive effects. The majority of studies have shown reduced side effects, increased quality of life and improved survival rates. Patients taking AHCC reported less nausea, vomiting and hair loss, and AHCC improved their body weight and appetite during chemotherapy. The immune effects of AHCC are not limited to cancer patients and have been applied to microbial infections as well. AOR’s AHCC is a powerful, evidence based option for people that want to support their immune function, combat stubborn infections and for patients undergoing certain types of chemotherapy.